Category Archives: Legislation

April is Irritable Bowel Syndrome (IBS) Awareness Month 2024

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, anywhere from 5-15% of the population in different countries on every continent of the world. In the U.S, this prevalence exceeds that of diabetes, chronic kidney disease, asthma, adults with chronic heart disease, and, by far, inflammatory bowel disease (IBD), with which …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2023

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, anywhere from 5-15% of the population in different countries on every continent of the world. In the U.S, this prevalence exceeds that of diabetes, chronic kidney disease, asthma, adults with chronic heart disease, and, by far, inflammatory bowel disease (IBD), with which …

Continue reading

14 Years and 15 IBS Awareness Months: Holding on to Hope 2021-2022

by Nina Pan, IBS Impact founder and primary blogger for IBS Impact. Nine years ago, on April 24, 2013, I wrote a post for IBS Awareness Month that began with some reflections on my personal experiences with IBS, as well as my motivations for IBS Impact. At that time, I had been living with IBS …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2022

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, at least 25 million and perhaps up to 58 million women, men and children in the United States and anywhere from 9-23% of the population in different countries on every continent of the world.  In the U.S, this prevalence exceeds that of …

Continue reading

13 Years and 14 IBS Awareness Months: Moving the IBS Community Forward 2020-2021

by Nina Pan, IBS Impact founder and primary blogger for IBS Impact. Eight years ago, on April 24, 2013, I wrote a post for IBS Awareness Month that began with some reflections on my personal experiences with IBS, as well as my motivations for IBS Impact. At that time, I had been living with IBS …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2021

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, at least 25 million and perhaps up to 58 million women, men and children in the United States and anywhere from 9-23% of the population in different countries on every continent of the world.  In the U.S, this prevalence exceeds that of …

Continue reading

Reps. Butterfield of North Carolina and McGovern of Massachusetts Co-Sponsor Functional Gastrointestinal and Motility Disorders Research Enhancement Act (HR 3396)

According to IFFGD and the official Congressional legislative database Congress.gov, earlier this month,Representative G.K. Butterfield (D-NC-1) and Representative James McGovern (D-MA-2)  officially became co-sponsors for HR 3396, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019. Each of them is co-sponsoring for the first time. IBS Impact thanks them for taking the time …

Continue reading

A Dozen Years and 13 IBS Awareness Months: Advances for the IBS Community 2019-2020

by Nina Pan, IBS Impact founder and primary blogger for IBS Impact. Seven years ago, on April 24, 2013, I wrote a post for IBS Awareness Month that began with some reflections on my personal experiences with IBS, as well as my motivations for IBS Impact. At that time, I had been living with IBS for …

Continue reading

April is Irritable Bowel Syndrome (IBS) Awareness Month 2020

April is Irritable Bowel Syndrome Awareness Month. IBS affects, depending on the source, at least 25 million and perhaps up to 58 million women, men and children in the United States and anywhere from 9-23% of the population in different countries on every continent of the world.  In the U.S, this prevalence exceeds that of diabetes, chronic …

Continue reading

Reps. Brownley of California, Suozzi of New York and Norton of the District of Columbia Co-Sponsor Functional Gastrointestinal and Motility Disorders Research Enhancement Act (HR 3396)

According to IFFGD and the official Congressional legislative database Congress.gov, last week, Representative Julia Brownley (D-CA-26), Representative Thomas Suozzi (D-NY-3) and Representative Eleanor Holmes Norton (D-DC-at large)  officially became co-sponsors for HR 3396, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019. Each of them was a co-sponsor of a previous version of …

Continue reading